DK30187D0 - Farmaceutisk praeparat til opnaaelse af en hoejviskos hydrogel eller suspension - Google Patents

Farmaceutisk praeparat til opnaaelse af en hoejviskos hydrogel eller suspension

Info

Publication number
DK30187D0
DK30187D0 DK030187A DK30187A DK30187D0 DK 30187 D0 DK30187 D0 DK 30187D0 DK 030187 A DK030187 A DK 030187A DK 30187 A DK30187 A DK 30187A DK 30187 D0 DK30187 D0 DK 30187D0
Authority
DK
Denmark
Prior art keywords
hydrogel
suspension
pharmaceutical preparation
vikos
getting
Prior art date
Application number
DK030187A
Other languages
English (en)
Other versions
DK30187A (da
Inventor
Bobby Liep Siang Kwee
Johannes Gerhardus Jo Egberink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK30187D0 publication Critical patent/DK30187D0/da
Publication of DK30187A publication Critical patent/DK30187A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DK030187A 1986-01-24 1987-01-20 Farmaceutisk praeparat til opnaaelse af en hoejviskos hydrogel eller suspension DK30187A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8600155 1986-01-24

Publications (2)

Publication Number Publication Date
DK30187D0 true DK30187D0 (da) 1987-01-20
DK30187A DK30187A (da) 1987-07-25

Family

ID=19847460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK030187A DK30187A (da) 1986-01-24 1987-01-20 Farmaceutisk praeparat til opnaaelse af en hoejviskos hydrogel eller suspension

Country Status (15)

Country Link
US (1) US4818517A (da)
EP (1) EP0231040B1 (da)
JP (1) JPH0764720B2 (da)
KR (1) KR940011241B1 (da)
AT (1) ATE62412T1 (da)
AU (1) AU597330B2 (da)
CA (1) CA1287580C (da)
DE (1) DE3769160D1 (da)
DK (1) DK30187A (da)
ES (1) ES2035847T3 (da)
GR (1) GR3002269T3 (da)
IE (1) IE59361B1 (da)
NZ (1) NZ218948A (da)
PT (1) PT84188B (da)
ZA (1) ZA87255B (da)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
EP0295337B1 (en) * 1987-06-16 1991-12-04 Akzo Nobel N.V. Two compartment syringe and method of manufacturing
EP0794795A1 (en) * 1994-03-24 1997-09-17 Boehringer Ingelheim Agrovet A/S Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ，インク． 男性勃起機能不全を治療するための改良された方法及び組成物
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
WO1999021562A1 (en) 1997-10-28 1999-05-06 Asivi, Llc Treatment of female sexual dysfunction
JP2003527159A (ja) * 1999-10-22 2003-09-16 アンタレス・ファーマ・インコーポレーテッド 薬剤カートリッジ及び注射装置
US6264987B1 (en) * 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6471995B1 (en) 2000-09-27 2002-10-29 Alkermes Controlled Therapeutics, Inc. Ii Apparatus and method for preparing microparticles using liquid-liquid extraction
US20020114843A1 (en) * 2000-12-27 2002-08-22 Ramstack J. Michael Preparation of microparticles having improved flowability
CA2472188C (en) * 2002-01-18 2011-06-21 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
ES2314182T3 (es) 2002-02-11 2009-03-16 Antares Pharma, Inc. Inyector intradermico.
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
EP2409707B8 (en) * 2004-04-15 2015-05-06 Alkermes Pharma Ireland Limited Polymer-based sustained release device
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US7080755B2 (en) 2004-09-13 2006-07-25 Michael Handfield Smart tray for dispensing medicaments
BRPI0614025A2 (pt) 2005-01-24 2012-12-25 Antares Pharma Inc injetores de jato
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2007131013A1 (en) 2006-05-03 2007-11-15 Antares Pharma, Inc. Two-stage reconstituting injector
CN101454030B (zh) * 2006-05-31 2013-06-26 巴克斯特国际公司 用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
WO2008021133A2 (en) 2006-08-09 2008-02-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2114346B1 (en) * 2007-01-25 2018-08-22 Hyperbranch Medical Technology, Inc. Applicators for multiple component formulations and the like
CA2680365A1 (en) * 2007-03-22 2008-10-02 Alkermes, Inc. Coacervation process
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
TWI461227B (zh) 2007-10-30 2014-11-21 Baxter Int 再生生物功能性膠原生物基質用來治療內臟或體壁缺陷的用途
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
EP3581224A1 (en) 2008-08-05 2019-12-18 Antares Pharma, Inc. Multiple dosage injector
US8579865B2 (en) 2009-03-20 2013-11-12 Antares Pharma, Inc. Hazardous agent injection system
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
AU2010262058B2 (en) * 2009-06-16 2013-08-29 Baxter Healthcare S.A. Hemostatic sponge
CN104323981B (zh) 2009-09-28 2019-03-12 精达制药公司 基本稳态药物递送的快速建立和/或终止
CA2784432C (en) * 2009-12-16 2019-01-15 Baxter Healthcare S.A. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
IT1400323B1 (it) * 2010-05-07 2013-05-24 Univ Degli Studi Torino Metodo per il rilascio controllato di un principio attivo
KR20130083393A (ko) 2010-06-01 2013-07-22 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
CA2801116C (en) 2010-06-01 2019-02-12 Baxter International Inc. Process for making dry and stable hemostatic compositions
CN102917691A (zh) 2010-06-01 2013-02-06 巴克斯特国际公司 用于生产干燥、稳定的止血组合物的方法
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US8496619B2 (en) 2011-07-15 2013-07-30 Antares Pharma, Inc. Injection device with cammed ram assembly
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
CA2851321C (en) 2011-10-11 2020-07-07 Baxter International Inc. Hemostatic compositions
US20130108671A1 (en) 2011-10-27 2013-05-02 Baxter Healthcare S.A. Hemostatic compositions
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
WO2013152323A1 (en) 2012-04-06 2013-10-10 Wotton Paul K Needle assisted jet injection administration of testosterone compositions
US9364611B2 (en) 2012-05-07 2016-06-14 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
WO2014124427A1 (en) 2013-02-11 2014-08-14 Travanty Michael Needle assisted jet injection device having reduced trigger force
ES2742046T3 (es) 2013-03-11 2020-02-12 Antares Pharma Inc Inyector de dosis con sistema de piñón
BR112015030612B1 (pt) 2013-06-21 2020-07-21 Ferrosan Medical Devices A/S método para preparar uma composição seca
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
PL3319596T3 (pl) * 2015-07-09 2024-04-15 Uniwell Laboratories Llc Farmaceutyczne kompozycje
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
SE431821B (sv) 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4693887A (en) * 1983-09-15 1987-09-15 The Kendall Company Microphase separated hydrogels for controlled release of bioactive materials
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物

Also Published As

Publication number Publication date
CA1287580C (en) 1991-08-13
KR940011241B1 (ko) 1994-12-03
KR870006893A (ko) 1987-08-13
IE59361B1 (en) 1994-02-09
JPS62190119A (ja) 1987-08-20
EP0231040A1 (en) 1987-08-05
ATE62412T1 (de) 1991-04-15
GR3002269T3 (en) 1992-12-30
ES2035847T3 (es) 1993-05-01
DE3769160D1 (de) 1991-05-16
EP0231040B1 (en) 1991-04-10
US4818517A (en) 1989-04-04
AU597330B2 (en) 1990-05-31
JPH0764720B2 (ja) 1995-07-12
IE870071L (en) 1987-07-24
DK30187A (da) 1987-07-25
AU6786187A (en) 1987-07-30
PT84188B (pt) 1989-03-30
NZ218948A (en) 1989-04-26
ZA87255B (en) 1987-08-26
PT84188A (pt) 1987-02-01

Similar Documents

Publication Publication Date Title
DK30187D0 (da) Farmaceutisk praeparat til opnaaelse af en hoejviskos hydrogel eller suspension
FI863990A0 (fi) Farmaseuttisen tai diagnostisen aineen oftalmologinen kantoainekoostumus
IT1170375B (it) Apparecchio che infonde insulina o glucosio nel soggetto diabetico sulla base di determinazioni di concentrazioni di glucosio ottenute senza bisogno di prelievi del sangue del paziente
CN100509858C (zh) 交联的多糖组合物
GB2007091A (en) Ophthalmic composition
ES2035259T3 (es) Compuesto absorbente.
ES2075468T3 (es) Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
KR890011609A (ko) 구충 분열체를 사용한 포자충증에 대한 생백신
KR910007508A (ko) 서방출 드레싱용 제제 및 이의 용도
DE3685992D1 (de) System zur kontrollierten freigabe von makromolekuelen.
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
FI864760A0 (fi) Ihmiskehoon istutettava keinotekoinen rauhanen
NL190693C (nl) Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
NO932053L (no) Nye farmasoeytiske preparater inneholdende en farmakologisk aktiv ioniserbar substans samt fremgangsmaate for fremstilling derav
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
Cifkova et al. Irritation effects of residual products derived from p (HEMA) gels: II. Compounds extracted from hydrogels
Poli et al. Influence of actin cytoskeleton on intra-articular and interstitial fluid pressures in synovial joints
ATE84228T1 (de) Spritze.
BG60089B2 (bg) Състав за отстраняване или инактивиране на вредни съставки в кръвта у хора и животни
RU96106336A (ru) Способ введения лекарственных средств в полость сустава
SU1702412A1 (ru) Способ моделировани недостаточности трипсина IN VIVo
GB1317858A (en) Process for producing articles from hydrophilic polymers appropriate for repeated or long-term-contact with living tissue or mucous membrane
JPS57200316A (en) Examination of pancreatic exocrine function
Rozkin et al. Comparative study of the anticoagulant activity of sulfated polysaccharides from marine brown algae
NO163654C (no) Mikrobobleforloeper i steril, injiserbar enhetsdoseringsform, fremgangsmaate til fremstilling av en vandig suspensjonav mikrobobler og anvendelse av mikrobobleforloeperen for injisering i blodstroemmen hos et levende vesen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment